Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that using the right diagnostic methods and careful sample handling is crucial for accurately diagnosing horse skin diseases.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Herbal products can be dangerous and cause serious health issues.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

An elderly woman's swollen, painful foot was found to be caused by a rare type of bone lymphoma, which improved with radiation treatment.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Suppressing certain hormones might help prevent prostate cancer.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.